China's Neurophth raises nearly $100m as it nears commercialisation of lead candidate

China's Neurophth raises nearly $100m as it nears commercialisation of lead candidate

Visuals from Neurophth Therapeutics' website

09 August, 2023

Edited by: Joymitra Rai

biotech Gene Therapy HongShan Neurophth Therapeutics ophthalmic diseases

Printed by Unregistered user on Mon, 14 Jul 2025 03:01:07 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese commercial NEV maker Derry Auto closes nearly $100m Series B round

US-listed Chinese biopharma firm Gracell to raise $150m in Vivo Capital-led PIPE deal

Read more from Greater China

Animoca Brands signs $100m Bitcoin deal with DDC Enterprise

Hong Kong’s VMS Group eyes PE secondaries to drive liquidity for LPs